2009
DOI: 10.1186/1472-6831-9-21
|View full text |Cite
|
Sign up to set email alerts
|

Association of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple β-defensins in gingival keratinocytes

Abstract: BackgroundHuman β-defensins (hBDs) are antimicrobial peptides with a role in innate immune defense. Our laboratory previously showed that a single nucleotide polymorphism (SNP) in the 5' untranslated region of the hBD1 gene (DEFB1), denoted -44 (rs1800972), is correlated with protection from oral Candida. Because this SNP alters the putative mRNA structure, we hypothesized that it alters hBD1 expression.MethodsTransfection of reporter constructs and evaluation of antimicrobial activity and mRNA expression leve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
50
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 49 publications
(57 citation statements)
references
References 70 publications
7
50
0
Order By: Relevance
“…C. albicans colonization was significantly increased in CD patients and was identified as an immunogen for ASCA (19), a serologic marker associated mainly with colonic involvement in CD (23). In line with the findings of a recent study (20), we provide a mechanism whereby the rs1800972 G allele might be linked to transactivation of DEFB1 expression through PPARγ. It also might account for the inefficacity of PPARγ-based therapy, such as 5-aminosalicylates, in the colon of CD patients with colonic involvement compared with UC patients.…”
Section: Discussionsupporting
confidence: 88%
“…C. albicans colonization was significantly increased in CD patients and was identified as an immunogen for ASCA (19), a serologic marker associated mainly with colonic involvement in CD (23). In line with the findings of a recent study (20), we provide a mechanism whereby the rs1800972 G allele might be linked to transactivation of DEFB1 expression through PPARγ. It also might account for the inefficacity of PPARγ-based therapy, such as 5-aminosalicylates, in the colon of CD patients with colonic involvement compared with UC patients.…”
Section: Discussionsupporting
confidence: 88%
“…β-Defensin production has been theorized as being under genetic control, with the involvement of copy number variations in DEFB4 , DEFB103 , and DEFB104 genes coding for hBD2 [Jaradat et al, 2013] as well as hBD3 and hBD4, reviewed in Cantsilieris and White [2013], or regulatory 5 ′ -untranslated region (UTR) polymorphisms in the DEFB1 gene encoding hBD1 [Sun et al, 2006;Milanese et al, 2007;Kalus et al, 2009;Nurjadi et al, 2013].…”
mentioning
confidence: 99%
“…Parameters such as structure, expression, virulence factors, and invasive properties are being investigated. Furthermore, the infection can be influenced by the genetic variations of the host, which can result in defective peptides (Kalus et al 2009). In the intestine, AMPs are produced by epithelial cells.…”
Section: Host Sidementioning
confidence: 99%